Page last updated: 2024-09-05

tv3326 and Idiopathic Parkinson Disease

tv3326 has been researched along with Idiopathic Parkinson Disease in 2 studies

Research

Studies (2)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	0 (0.00)	18.2507
2000's	1 (50.00)	29.6817
2010's	1 (50.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Bolognesi, ML; Cavalli, A; Melchiorre, C; Minarini, A; Recanatini, M; Rosini, M; Tumiatti, V	1
Affini, A; Hagenow, S; Lutsenko, K; Reiner, D; Stark, H	1

Reviews

1 review(s) available for tv3326 and Idiopathic Parkinson Disease

Article	Year
Multi-target-directed ligands to combat neurodegenerative diseases. Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3 Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid	2008

Article

Year

Multi-target-directed ligands to combat neurodegenerative diseases.

Journal of medicinal chemistry, 2008, Feb-14, Volume: 51, Issue:3

Topics: Acetylcholinesterase; Alzheimer Disease; Amyloid beta-Peptides; Antioxidants; Binding Sites; Calcium Channel Blockers; Chelating Agents; Cholinesterase Inhibitors; Humans; Huntington Disease; Ligands; Multiple Sclerosis; Neurodegenerative Diseases; Neurofibrillary Tangles; Neurotransmitter Agents; Parkinson Disease; Plaque, Amyloid

2008

Other Studies

1 other study(ies) available for tv3326 and Idiopathic Parkinson Disease

Article	Year
Rasagiline derivatives combined with histamine H Bioorganic & medicinal chemistry letters, 2019, 10-01, Volume: 29, Issue:19 Topics: Histamine H3 Antagonists; Humans; Indans; Monoamine Oxidase Inhibitors; Parkinson Disease; Receptors, Histamine H3	2019